AMENDMENT NO. 5

Company

COSCIENS Biopharma Inc.

Filed

May 18, 2010

Accession Number

0000912282-10-000574

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →